We performed a multicenter evaluation of ligase chain reaction (LCR) 
Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen (4). It is a major cause of pelvic inflammatory disease and can cause serious disease in newborn infants exposed during passage through an infected birth canal. In the United States, with an estimated four million infections occurring each year and costs running into several billion dollars, it is imperative that effective Chlamydia control programs be developed (11) . Symptomatic men and women are likely to receive appropriate therapy because Centers for Disease Control and Prevention guidelines now call for the inclusion of antichlamydial therapy into treatment regimens for those conditions which are associated with chlamydiae. A truly effective Chlamydia control program must be aimed at reducing the reservoir of infected asymptomatic individuals who make up the bulk of prevalent infections and are responsible for maintaining transmission of the infection within a community.
Treatment is relatively simple and straightforward, with a week's treatment with doxycycline being highly effective (13) . The recent introduction of single-dose therapy with azithromycin heralds even more readily acceptable treatment regimens (8) . Thus, the challenge continues to be the accurate diagnosis of chlamydial infection.
For many years, isolation in tissue culture (TC), usually with cycloheximide-treated McCoy cells, has been the diagnostic test of choice (9) . This has not been a readily available procedure because it requires considerable technical expertise and the maintenance of a cell culture facility. The introduction of nonculture tests, such as direct fluorescent-antibody assay (DFA) and enzyme immunoassays, to detect chlamydial antigens in clinical specimens has greatly increased access to chlamydial diagnostic tests (9, 12) . However, these tests have been recognized as relatively insensitive compared with culture and, as is true for most nonculture methods, can yield falsepositive results that could have important social consequences. In addition, during evaluations of nonculture diagnostic tests, it became increasingly apparent that culture itself was far from perfect as a diagnostic test. While its specificity, by definition, is essentially 100%, the sensitivity of culture, even in excellent laboratories, seldom exceeds 90%, is typically between 75 and 85% (10), and sometimes falls below 50%.
Thus, there continues to be a need for better nonculture diagnostic tests, with improved sensitivity and specificity compared with those of antigen methods. Some nucleic acid probes have been made available, but they have not been shown to be markedly more sensitive than the antigen detection methods (5) . The use of amplified DNA techniques, such as ligase chain reaction (LCR) and PCR, offer the possibility of increasing sensitivity through amplification (1, 2, 3, 6, 7) . Both techniques increase the number of specific target DNA sequences to enhance sensitivity. Amplified DNA products can be detected by enzyme immunoassay by using standard photometric detection of a color product.
We report here the results of a multicenter evaluation of LCR for the detection of C. trachomatis in women. The target DNA sequence used for this assay lies within the cryptic plasmid. There are 7 to 10 copies per chlamydial particle, thus theoretically providing a further increment in sensitivity over chromosomal DNA detection. Specimen collection. Specimens were collected in a randomized order for isolation or LCR. Special transport medium was supplied for each test. For cell culture, the medium used was 2SP or TC medium containing antibiotics (50 p,g of streptomycin per ml or 10 ,ug of gentamicin per ml, 100 p,g of vancomycin per ml, and 10 U of nystatin per ml) to kill contaminating bacteria or fungi (9) . Specimens were collected after the endocervical canal had been cleaned by the removal of discharge with large cotton swabs or sponges. Then, either a cytobrush or a dacron swab was rubbed against the endocervical canal. Swabs were left in the proprietary LCR transport medium.
MATERIALS AND METHODS
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Specimens were transported to the laboratory on the day of collection and were stored at 4°C prior to the inoculation of cells. Isolation attempts were performed within 24 h of collection. The remaining isolation specimen was then frozen at -70°C in case it was needed for further tests. LCR specimens were transported to the laboratory within 24 h of collection. If specimens could be processed within 4 days, they were stored at 4°C; otherwise, they were stored at -70°C (up to DFA and likely represented the testing of specimens that contained dead EBs, perhaps because of the loss of viability by chlamydiae during storage or transit. A smaller subset (34 of 84) of LCR-positive and TC-negative specimens were DFA negative but could be shown to contain chlamydial genes because subsequent LCRs for the MOMP gene were positive. These specimens probably represent the real increment in sensitivity for LCR DNA amplification over those of enzyme immunoassays, DFA, and direct DNA probe technology. These specimens were both TC and DFA negative but tested positive for two different chlamydial genes (cryptic plasmid and MOMP). The specimens that could be verified by DFA actually represent those specimens for which LCR is more efficient than culture in that it detects dead particles and controls for variations in laboratory culture technique and the conditions of transport. The detection of dead chlamydiae detracts from the use of LCR as the test of cure if one collected Of the specimens that were TC positive and LCR negative, approximately half (7 of 13) were reported as LCR positive when they were tested 3 to 7 days after the original test. There was one sample which became LCR positive only after the sample was diluted. The other five specimens did not become LCR positive but were found to be positive with TC sediment rather than the original LCR material. Thus, it is likely that the failure of these specimens to be LCR positive reflected either the presence of inhibitors in the sample or possibly sampling variation. This was a demonstrated problem with approximately 3% (8 of 234) of all the positive specimens. Cervical specimens have been found by some workers to contain inhibitors of PCR tests for chlamydiae (2) .
The overall LCR sensitivity was 94%, and its specificity was 99.9%. The corresponding sensitivity and specificity of culture were 65% and, by definition, 100%, respectively. The LCR test obviously offers a highly sensitive and specific way of detecting the C. trachomatis cryptic plasmid in clinical specimens. The excellent results seen with specimens shipped to Chicago (Table 1) for LCR testing indicates the potential usefulness of this technology for surveys performed at distant locations.
The basic advantage of LCR appears to be its ability to detect nearly all the specimens that are chlamydia positive by culture as well as those that had sufficient EBs to be DFA positive. Beyond this, there is a modest increase in the sensitivity of LCR over that of existing technology (culture and DFA additively) in that 15% of specimens were confirmed only by other gene amplification procedures with a different chlamydia target sequence. Nevertheless, the basic advantage of the LCR is its efficient detection of highly positive specimens. Its specificity was very high (99.9%), meaning the predictive values of positive results would be over 80%, even in lowprevalence (2%) populations.
Although the LCR test for cervical chlamydial infection appears to be the most sensitive (94%) of the commercially developed nonculture tests evaluated by these investigators, it could still be improved upon. A small subset (5.5%) of positive specimens obtained by culture were not positive by LCR. The subsequent positive tests for chlamydial genes in these specimens suggest that labile inhibitors are involved. Whether LCR or PCR is more sensitive or more susceptible to inhibitors must await suitably designed parallel evaluations.
In addition, there is a potential for DNA contamination with the use of LCR. Two of the five facilities did experience this problem. It was detected when negative controls tested positive. However, by employing strict guidelines for specimen flow, isolation, and routine cleanup, laboratories engaged in DNA amplification procedures can avoid DNA contamination. Incoming specimen (target) areas and product areas should be kept separate, and airflow should be limited. The amplified product should be destroyed at the end of routine processing. It is likely that the routine cleaning of equipment and work areas with bleach would be useful. Certainly, the inclusion of appropriate controls is mandatory, and environmental sampling may be warranted.
The exceptional performance profile of the LCR test suggests that it may well become a test of choice for the diagnosis of chlamydial infection of the genital tract. Similarly good results were obtained with first-catch urine and urethral swab specimens from men with and without urethritis and, perhaps of even greater interest, with urine specimens from women. Those results will be reported elsewhere. However, even when only the results with cervical specimens presented here are considered, it is quite obvious that the LCR test is a serious candidate to be one of the tests of choice for the diagnosis of chlamydial infection.
